A case of rare anti-Hro alloantibody in a tertiary care center in India
- PMID: 31360012
- PMCID: PMC6580840
- DOI: 10.4103/ajts.AJTS_26_18
A case of rare anti-Hro alloantibody in a tertiary care center in India
Abstract
Anti-Hro is an alloantibody produced in individuals with -D- phenotype after a sensitizing event. Owing to the rarity of this antigen negative unit, registration in rare donor registries helps in procuring blood components at the earliest. We had a patient of -D- with anti-Hro antibody who required 7 units of red cells which was unavailable at our center. The patients near relatives were typed in search of a similar phenotype blood. Search was made for the rare units and Japanese Red Cross Society, American Red Cross Society, and International Blood Group Reference Laboratory, United Kingdom was contacted. Patient's brother and mother were typed as -D- and one unit from each of them was collected, irradiated, and transfused to the patient. Five units were imported from the Japanese Red Cross Society, Japan. Accessibility for identification and confirmation of rare blood groups and provision of the same can be centralized and liaison with the international registries can go a long way in the provision of blood components at the earliest.
Keywords: Anti-Hro antibody; international rare donor registry; rare blood group.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Identification of rare anti-f alloantibody in a tertiary care center in India.Asian J Transfus Sci. 2024 Jan-Jun;18(1):131-134. doi: 10.4103/ajts.ajts_22_21. Epub 2022 May 26. Asian J Transfus Sci. 2024. PMID: 39036692 Free PMC article.
-
Antibody screening and identification in donors and general patients at a tertiary care teaching hospital in Western India.Asian J Transfus Sci. 2019 Jan-Jun;13(1):34-38. doi: 10.4103/ajts.AJTS_94_17. Asian J Transfus Sci. 2019. PMID: 31360008 Free PMC article.
-
A decade of rare donor services in the United States. Report of the American Red Cross Rare Donor Registry (1981-1990).Vox Sang. 1992;63(3):186-91. doi: 10.1111/j.1423-0410.1992.tb05098.x. Vox Sang. 1992. PMID: 1448963
-
[Advancement in the preparation of red cell concentrates and platelet concentrates].Masui. 2011 Jan;60(1):23-30. Masui. 2011. PMID: 21348247 Review. Japanese.
-
Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.Immunohematology. 2007;23(2):75-80. Immunohematology. 2007. PMID: 18004938 Review.
Cited by
-
Molecular characterization of rare D--/D-- variants in individuals of Indian origin.Blood Transfus. 2022 Jan;20(1):59-65. doi: 10.2450/2020.0183-20. Epub 2020 Nov 27. Blood Transfus. 2022. PMID: 33263520 Free PMC article.
-
Rare blood group registry in India-current challenges and future perspectives.Front Genet. 2023 Sep 11;14:1264853. doi: 10.3389/fgene.2023.1264853. eCollection 2023. Front Genet. 2023. PMID: 37779913 Free PMC article.
References
-
- Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M. Rossi's Principles of Transfusion Medicine. 4th ed. West Sussex: Blackwell Publishing; 2009.
-
- Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Technical Manual. 18th ed. Bethesda, Maryland: American Association of Blood Banks; 2014.
-
- Hirose M, Nakanishi K, Kaku S, Moro H, Hodohara K, Aotani H, et al. Fetal hemolytic disease due to anti-Rh17 alloimmunization. Fetal Diagn Ther. 2004;19:182–6. - PubMed
-
- Salamat N, Bhatti FA, Hussain A, Ziaullah Anti-Rh17 (anti-hr0): A rare diagnostic and management problem. J Pak Med Assoc. 2004;54:215–8. - PubMed